Currently Viewing:
Newsroom
Currently Reading
Co-occurrence of Certain Migraine Symptoms Indicates a Common Pathophysiology
November 21, 2018 – Laura Joszt
Investigational Drug Gives Hope to Patients With Rare but Aggressive Blood Disease
November 20, 2018 – Laura Joszt
Pain Acceptance May Lower Migraine-Related Disability
November 19, 2018 – Jaime Rosenberg
Genetic Risk Score May Be Effective for Predicting Migraine Response to Triptans
November 16, 2018 – Alison Rodriguez
Use of Narcotics for Migraine Treatment in the ED Has Dropped Significantly
November 12, 2018 – Jaime Rosenberg
Intense Support for Hospitalized Patients With COPD Results in Fewer Readmissions
November 12, 2018 – Allison Inserro
Headache Specialists Dissatisfied With Migraine Care in the ED
November 10, 2018 – Alison Rodriguez
Antiviral Therapy Prevents HCV in Patients Receiving Infected Donor Hearts
November 09, 2018 – Jaime Rosenberg
Vagus Nerve Stimulation Quickly and Consistently Reduces Pain Intensity, Rescue Medication Use in Migraine
November 08, 2018 – Jaime Rosenberg

Co-occurrence of Certain Migraine Symptoms Indicates a Common Pathophysiology

Laura Joszt
Patients who have migraine often suffer from coexisting issues, such as sleep difficulties, vertigo, and dizziness. A study evaluating the presence of certain symptoms in patients with migraine indicated that some may have a common pathophysiology.
Patients who have migraine often suffer from coexisting issues, such as sleep difficulties, vertigo, and dizziness. According to a new paper published in Pain Medicine, patients with chronic migraine (CM) were more likely to have co-occurring symptoms that affect quality of life than patients with episodic migraine (EM).

The researchers evaluated the presence of certain symptoms in patients with EM and CM and sought to determine the association between these symptoms and Migraine Disability Assessment (MIDAS) scores. Overall, 897 EM patients and 183 CM patients were included in the study.

The authors found that vertigo/dizziness, cutaneous allodynia, concentration-related impairment in function, and abnormal sleep latency were significantly more frequent in patients with CM. These patients also had higher MIDAS and visual analog scale for pain scores.

As for cranial autonomic symptoms (CAS), except for rhinorrhea and facial/forehead sweating, which were more prevalent in patients with CM, there were no significant differences between the 2 groups. Among the overall study population, 69.4% had at least 1 of the CAS and 61.4% had vertigo/dizziness.

The researchers found that abnormal sleep latency and concentration-related impairment in function were more likely to occur in patient groups with CAS, vertigo/dizziness, and cutaneous allodynia than patients without those symptoms.

In a majority (60%) of patients with migraine, it took longer than 30 minutes to fall asleep, and for 16.7% of patients, it took patients longer than 30 minutes more than 3 times a week. Among the CM population, 39.3% had sleep latency longer than 30 minutes more than 3 times a week.

In the overall study population, CAS, vertigo/dizziness, and cutaneous allodynia tended to co-occur.

“One of the most important findings in our study was the coexistence of CAS, vertigo/dizziness, and cutaneous allodynia in patients with migraine,” the authors wrote.

The trigeminovascular system is thought to have a role in CAS. Cortical spreading depression and migraine-related transmitters, such as calcitonin gene-related peptide, explain migraine with vertigo, but experimental studies have now also indicated a possible connection between vestibular and trigeminal nuclei. Finally, cutaneous allodynia is associated with trigeminal nucleus caudalis.

As a result of currently known mechanisms and the co-occurrence of CAS, vertigo/dizziness, and cutaneous allodynia, the authors believe sensitization of trigeminal nuclei may be responsible for generating the symptoms.

“The co-occurrence of CAS, vertigo/dizziness, and cutaneous allodynia in migraine suggests that these symptoms have a common pathophysiology that varies depending on the activation of trigeminal pathways,” the authors concluded.

Reference

Ceylan M, Yalcin A. Coexistence of symptoms associated with trigeminal pathways in chronic and episodic migraine and the effects on quality of life. [published online September 14, 2018.] Pain Med. doi: 10.1093/pm/pny118.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up